Delivery Order SPE2DE24D0021-SPE2D626F30DW
- Not listed
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,300 for the provision of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits, with an ultimate completion date of February 17, 2026. This fixed-price contract with economic price adjustment was issued by the Department of Defense's Medical Supply Chain on December 17, 2025, and will be performed at Fisher Scientific's principal facility in Pittsburgh, Pennsylvania. No set-aside designation was applied to this...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $2.2K on December 4, 2025, for SOFIA 2 FLU + SARS antigen fluorescent diagnostic test kits. The contract, which carries an ultimate completion date of February 3, 2026, was issued by the Department of Defense's Medical Supply Chain without set-aside designation, indicating open competition. Performance will be fulfilled from Fisher Scientific's principal place of business in Pittsburgh, Pennsylvania. This...
- Fisher Scientific Company L.L.C. received a delivery order award valued at $1,100 for the supply of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. The contract was awarded on January 28, 2026, by the Department of Defense's Medical Supply Chain with an ultimate completion date of March 26, 2026. The award utilizes fixed-price pricing with economic price adjustment terms and was issued without a set-aside designation, indicating open competition. Performance will be executed from...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,300 on January 6, 2026, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits under a fixed-price contract with economic price adjustment provisions. The award, issued by the Department of Defense's Medical Supply Chain, is scheduled for completion by March 5, 2026, and will be performed in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger vehicle and was awarded without...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,100 on January 26, 2026, by the Department of Defense's Medical Supply Chain for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits, with an ultimate completion date of March 24, 2026. This is a fixed-price contract with economic price adjustment provisions and represents a child contract under a larger procurement vehicle. The award utilized no set-aside designation, indicating open competition among qualified...
- Fisher Scientific Company L.L.C. received a delivery order award (4570407195) from the Department of Defense's Medical Supply Chain on January 6, 2026, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. The contract carries a ceiling value of $5,500 and is structured as a fixed-price delivery order with economic price adjustment provisions. Performance will be completed by March 5, 2026, at Fisher Scientific's principal place of business in Pittsburgh, Pennsylvania. This award...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $5,500 for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits by the Department of Defense's Medical Supply Chain. The contract is a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of March 12, 2026. The order will be fulfilled from Fisher Scientific's principal place of business in Pittsburgh, Pennsylvania. This delivery order...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,105.84 for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price delivery order with economic price adjustment was issued on August 7, 2025, with an ultimate completion date of October 3, 2025. The award was made through open competition with no set-aside designation. The work will be performed in Pittsburgh, Pennsylvania, and is funded by the Defense Department's Medical Supply Chain...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract valued at $11,000 for the supply of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. The contract, awarded January 7, 2026, with an ultimate completion date of March 6, 2026, was issued by the Department of Defense's Medical Supply Chain without a set-aside designation, indicating open competition. The work will be performed in Pittsburgh, Pennsylvania, where Fisher Scientific maintains its principal place of...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,750 by the Department of Defense's Medical Supply Chain for SOFIA 2 FLU + SARS antigen fluorescent diagnostic test kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of March 4, 2026. This award represents a child contract issued under a larger indefinite delivery vehicle and involves no set-aside designation, indicating...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F30DWDelivery Order
Fisher Scientific Company L.L.C. received a delivery order award valued at $2,750 for SOFIA 2 FLU + SARS 25S diagnostic supplies from the Department of Defense's Medical Supply Chain, with an ultimate completion date of March 26, 2026. The award, issued on January 28, 2026, employs fixed-price pricing with economic price adjustment terms and carries no set-aside designation, indicating open competition. This delivery order is a child contract under a larger procurement vehicle, leveraging Fisher Scientific's established relationship and capabilities as a supplier of laboratory equipment, diagnostic test kits, and medical supplies to federal healthcare and research institutions. Fisher Scientific, headquartered in Pittsburgh, Pennsylvania, is a well-established federal vendor specializing in scientific products and laboratory supplies across multiple government agencies including the Department of Veterans Affairs, National Institutes of Health, and the Indian Health Service. The company maintains a significant Indefinite Delivery Vehicle with the VA's Veterans Integrated Service Network 1 valued at $1.65 million through 2030, demonstrating sustained credibility in supplying specialized laboratory reagents and diagnostic equipment to federal healthcare operations. This modest delivery order for influenza and SARS testing supplies aligns with the company's core competencies in providing diagnostic and laboratory solutions supporting federal medical and research missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 1/27/26 |